The Greater Cannabis Co., Inc. engages in the business of cannabis related investment and development opportunities through online retail store, direct equity investments, joint ventures, licensing agreements, or acquisitions. The company is headquartered in Baltimore, Maryland and currently employs 1 full-time employees. The company went IPO on 2018-07-09. The firm is involved in additional research and development of cannabinoid-based therapeutics that reduce disruptive symptoms in patients suffering from neuropsychiatric disorders. The firm also focuses on developing new formulations around cannabinoid therapeutics. Its wholly owned subsidiary is Biocanrx, Inc.
Greater Cannabis Company Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Greater Cannabis Company Inc 주요 수익원은 Consumer이며, 최신 수익 발표에서 수익은 3,625,913,245입니다. 지역별로는 Asia/Pacific이 Greater Cannabis Company Inc의 주요 시장이며, 수익은 4,207,844,628입니다.
Greater Cannabis Company Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Greater Cannabis Company Inc의 순손실은 $0입니다.